Allos Therapeutics: News mgreer@allos.com or Media Madeline Malia, +1 609-

The article discusses the strategic collaboration agreement between

entered into a strategic collaboration agreement with Allos Therapeutics, Inc., to

ALLOS SIGNS $360M FOLOTYN PACT WITH MUNDIPHARMA. After

Allos Therapeutics Enters Into Collaboration And Licensing Agreement With

Jan 20, 2012 . In May 2011, Allos entered into a strategic collaboration agreement with

Mar 19, 2012 . In May 2011, Allos Therapeutics, Inc. (the "Company") entered into a strategic

May 12, 2011 . Allos Therapeutics, Inc. (NASDAQ: ALTH), und Mundipharma International

Tags: News ALLOS Therapeutics ALTH biopharmaceutical blood cancers

Jan 20, 2012 . In May 2011, Allos entered into a strategic collaboration agreement with

May 11, 2011 . Allos and Mundipharma also announced that they will jointly fund development

Apr 11, 2012 . Allos and Mundipharma have a strategic collaboration to co-develop Folotyn;

Mar 26, 2012 . Allos and Mundipharma will jointly fund worldwide development costs, initially on

Mundipharma International Limited – Product Pipeline Review. . Allos

Mar 7, 2012 . Allos Narrows Loss - Analyst Blog. . Mundipharma International Limited's

Mar 6, 2012 . In May 2011, Allos entered into a strategic collaboration agreement with

May 10, 2011 . Under the deal with Mundipharma International Corp. Ltd., Westminster-based

Allos Therapeutics Enters Into Collaboration And Licensing Agreement With

Apr 20, 2012 . Allos Therapeutics (ALTH) to Receive Payment of $50M from Collaboration with

May 10, 2011 . Allos to Receive $50 Million Upfront Payment and Retain Full Commercialization

May 10, 2011 . The tie up allows Allos to commercialize Folotyn in the US and Canada, whereas

USA-based Allos Therapeutics (Nasdaq: ALTH) and privately-held Mundipharma

May 10, 2011 . Allos Therapeutics and Mundipharma Announce Strategic Collaboration for

Mundipharma International Ltd. News. progress Loading the latest news for

Allos Therapeutics has signed a co-development and commercialisation

Research about MUNDIPHARMA GmbH, including news, information, and

Mar 22, 2012 . Per the terms of the deal, the sole responsibility of commercializing the drug in

Dec 1, 2011 . Allos Therapeutics Enters Into Collaboration And Licensing Agreement With

May 12, 2011 . Mundipharma agreed to pay $310.5 million in milestones, gaining rights outside

Jun 8, 2011 . Allos and Mundipharma jointly finance the development costs, primarily on the

May 10, 2011 . Allos Therapeutics, Inc. (ALTH) and Mundipharma International Corp. Ltd. said

Results 1 - 10 . We note that Allos inked a co-development and commercialization deal with

Jan 23, 2012 . Per the terms of the deal, the sole responsibility of commercializing the drug in

Moreover, we are positive on the deal inked by Allos in May 2011 with

Search for: "Mundipharma". Allos Therapeutics Receives Negative Opinion from

Allos Therapeutics, Inc. (ALTH) and Mundipharma AG Announce Strategic

Jan 31, 2012 . Allos Therapeutics has announced the interim results from the ongoing . (

12 mai 2011 . Les sociétés Allos Therapeutics, Inc. (NASDAQ : ALTH) et Mundipharma

Feb 6, 2012 . Per the terms of the deal, the sole responsibility of commercializing the drug in

Mundipharma International and its associate network has built a portfolio through

May 10, 2011 . Allos Therapeutics (ALTH) & Mundipharma Announce Collaboration for

May 11, 2011 . Allos Therapeutics in Westminster, Colorado and Mundipharma International

May 11, 2011 . Allos Therapeutics, a biopharmaceutical company engaged in the development

May 13, 2011 . USA-based Allos Therapeutics (Nasdaq: ALTH) and privately-held Mundipharma

Jan 3, 2012 . Mundipharma International Limited – Product Pipeline Review – H2 . Its status

Jan 20, 2012 . In May 2011, Allos entered into a strategic collaboration agreement with

May 11, 2011 . WESTMINSTER, Colo.—Allos Therapeutics, Inc. and Mundipharma International

Apr 20, 2012 . In May 2011 , Allos entered into a strategic collaboration agreement with

Allos Therapeutics (April 20, 2012). Positive Opinion on Flutiform® in Europe

Apr 20, 2012 . In May 2011, Allos entered into a strategic collaboration agreement with

Sitemap